Trial intelligence / Profile preview

Exercise and Hormone Treatment in a Human Experimental Model of Menopause

NCT02525276Unknown

Sponsor
Rigshospitalet
Start
Aug 2015
Primary completion
Aug 2018
01

Overview

Randomised, open-label trial in metabolic syndrome (4 arms), sponsored by Rigshospitalet. Primary endpoint: Insulin sensitivity at 1 year. Status: unknown.

02

Conditions

metabolic syndrome

Beyond the preview

Go deeper on NCT02525276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02525276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call